文献速递神经免疫认知障碍与痴呆

儿童期与成人期起病多发性硬化患者生活质量的决定因素

Determinants of quality of life in pediatric- and adult-onset multiple sclerosis.
PubMed 文献 · Neurology · 2019-11-15

基于瑞典全国多发性硬化登记研究,纳入5094例18-50岁患者(354例儿童期起病),比较两组EQ-VAS评分并探索生活质量决定因素。调整混杂因素后,儿童期与成人期起病患者的EQ-VAS无差异(β=0.99,95%CI -0.89至2.87)。复发、严重神经残疾及较高心理评分与较低生活质量相关,而信息处理效率较高和一线疾病修饰治疗暴露与较高生活质量相关。

要点

  • 儿童期与成人期起病的多发性硬化患者在成年期生活质量无显著差异。
  • 复发、EDSS≥6.0及较高MSIS-29心理评分与较低生活质量一致相关。
  • 较高信息处理效率和一线疾病修饰治疗暴露与较高生活质量相关。

核心结论

  • 儿童期起病与成人期起病的多发性硬化患者在成年期生活质量无差异。
  • 减少神经残疾和改善心理状态可能有助于提高多发性硬化患者的生活质量。

研究设计与样本

  • 基于瑞典全国多发性硬化登记系统的观察性研究,纳入5094例18-50岁确诊多发性硬化患者,其中354例(6.9%)为儿童期起病。
  • 收集2011-2019年约每年一次的人口学特征、EQ-5D-3L、MSIS-29、EDSS、符号数字模态测验评分、复发及疾病修饰治疗暴露数据。
  • 主要结局为EQ-5D视觉模拟量表(EQ-VAS)评分,采用线性混合模型比较两组间及组内决定因素。

主要发现

  • 共记录21357个独立EQ-5D评分,大多数参与者为女性(70.0%),复发起病病程占98.1%。
  • 调整混杂因素后,儿童期起病与成人期起病患者的EQ-VAS评分无差异(β=0.99,95%CI -0.89至2.87)。
  • 经历复发、严重神经残疾(EDSS≥6.0 vs <3.0)及较高MSIS-29心理评分与较低生活质量一致相关。
  • 较高信息处理效率和一线疾病修饰治疗暴露与较高生活质量评分相关。

关键数值与推荐

  • 儿童期起病与成人期起病比较的EQ-VAS β系数为0.99(95%CI -0.89至2.87)。
  • 严重神经残疾定义为EDSS≥6.0,对照为EDSS<3.0。

临床怎么用

  • 临床应关注减少神经残疾和改善心理状态,以可能提高多发性硬化患者的生活质量。
  • 一线疾病修饰治疗暴露与较高生活质量相关,但需结合个体情况决策。

局限性

  • 本研究为观察性登记研究,无法确立因果关系。
  • 仅纳入18-50岁且有至少2次EQ-5D测量的患者,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate quality of life (QoL), measured by the EQ-5D, in adults with pediatric-onset multiple sclerosis (POMS) or adult-onset multiple sclerosis (AOMS) and explore determinants of QoL in both groups. METHODS: Data were collected from the nationwide Swedish multiple sclerosis (MS) registry. Demographic characteristics, EQ-5D-3 level, Multiple Sclerosis Impact Scale (MSIS-29) score, Expanded Disability Status Scale (EDSS) score, Symbol Digit Modalities Test score, relapses, and disease-modifying therapy (DMT) exposure were collected on an approximately annual basis (2011-2019). Patients with definite MS with ≥2 EQ-5D measurements collected between ages 18 and 50 were included. The principal outcome was the EQ-5D visual analogue scale (EQ-VAS) score. Linear mixed models compared all available EQ-VAS scores between patients with POMS and patients with AOMS and determinants of EQ-VAS among patients with POMS and patients with AOMS (assessed separately). RESULTS: A total of 5,094 persons met inclusion criteria: 354 (6.9%) had POMS. A total of 21,357 unique EQ-5D scores were recorded. Most participants were female (70.0%) with a relapsing-onset disease course (98.1%). There was no difference in EQ-VAS scores between patients with POMS and patients with AOMS following adjustment for confounders (β-coefficient for patients with POMS vs patients with AOMS [reference]: 0.99; 95% confidence interval -0.89 to 2.87). Experiencing a relapse, severe neurologic disability (EDSS ≥6.0 vs <3.0), and higher MSIS-29 psychological score were consistently associated with lower QoL, while higher information processing efficiency and exposure to first-line DMTs were associated with higher QoL scores in both groups. CONCLUSIONS: There were no differences in QoL between patients with POMS and patients with AOMS in adulthood. Findings provide support for a focus on reducing neurologic disability and improving psychological status as approaches to potentially improve the QoL of persons with MS.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. McKay KA, Ernstsson O, Manouchehrinia A, et al. Determinants of quality of life in pediatric- and adult-onset multiple sclerosis. Neurology. 2019. PMID: 31732567. doi:10.1212/WNL.0000000000008667

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。